Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.

Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. · 2019

Read Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. by Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6441236.txt.

Description

Fiori and co-authors pick apart how the fibroblasts that gather around tumors help cancers grow and shrug off treatment, with a shape-shifting switch at the center. Fibroblasts are the most common support cells in solid tumors, reaching up to 80 percent of tumor mass in pancreatic cancer. They talk with cancer cells through secreted signals, small vesicles, shared fuels, and the matrix itself.

Through that cross-talk, fibroblasts can push cancer cells to loosen up and move, switch on survival paths, keep stem-like programs alive, and rewire how cells burn fuel. Newly found fibroblast subtypes make a single attack risky: wiping out the wrong subset could help the tumor. Turning the rich lab picture into plans that work in the clinic remains the unfinished work.

Catalog record

CREATORFiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE86 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6441236

Browse the full library · About the Tower of Babel